Guidelines for the prevention and management of children and adolescents with COVID-19.
Enmei LiuRosalind Louise SmythQinyuan LiAmir QaseemIvan D FlorezJoseph L MathewYasser Sami AmerJanne EstillQuan LuZhou FuXiaoxia LuEdwin Shih-Yen ChanJürgen SchwarzeGary Wing-Kin WongToshio FukuokaHyeong Sik AhnMyeong Soo LeeDetty NurdiatiBin CaoWenwei TuYuan QianShunying ZhaoXiaoyan DongXiaoping LuoZhimin ChenGuobao LiXiaobo ZhangXiaodong ZhaoHongmei XuFeng XuYuan ShiRuiqiu ZhaoYao ZhaoJunqiang LeiXianlan ZhengMengshu WangShu YangXixi FengLiqun WuZhihui HeShihui LiuQi WangYang SongZhengxiu LuoQi ZhouGordon GuyattYaolong ChenQiu LiPublished in: European journal of pediatrics (2022)
• The updated guideline provides key recommendations pertinent to the following issues: identification of prognostic factors for death or pediatric intensive care unit admission; the use of remdesivir, systemic glucocorticoids and antipyretics, intravenous immunoglobulin for multisystem inflammatory syndrome in children, and high-flow oxygen by nasal cannula or non-invasive ventilation for acute hypoxemic respiratory failure; breastfeeding; vaccination; and the management of pediatric mental health.
Keyphrases
- respiratory failure
- mechanical ventilation
- prognostic factors
- intensive care unit
- extracorporeal membrane oxygenation
- mental health
- acute respiratory distress syndrome
- coronavirus disease
- sars cov
- clinical practice
- emergency department
- young adults
- oxidative stress
- preterm infants
- high dose
- low dose
- mental illness
- case report
- drug induced